Difference between revisions of "Part:BBa K2052016"

Line 37: Line 37:
  
  
         [[File:Fimhgraphicformodeling.jpeg|900px]]
+
         [[File:MODELING1.jpeg|900px]]
  
  

Revision as of 11:47, 16 October 2016


FimH site directed mutated with RPMrel and ButCoat


Usage & Biology

This part is composed of a protein coding section (fimH+ RPMrel), a double terminator, arabinose induced promoter, RBS and another protein coding sequence (ButCoaT).


FimH protein is a subunit of a structure called pilus, which naturally occurs in some strains of e.coli. This protein coding sequence made our bacteria to have fimH adhesin. Normally, in pathogenic strains of E.coli, at the end of each pilus, there is a carbohydrate binding protein “Lectin” which allows the binding to sugar mannose. However, we used a non- pathogenic strain BL21 in our project so it doesn’t contain Lectin in it’s pili. Thus our bacteria isn’t able to bind to bind to any non-cancerous eukaryotic cells even though it had fimH. Then, to make the binding system cancer specific and to make our bacteria bind only to cancerous cells, we used RPMrel. RPMrel is a 9 amino acid colon tumor specific binding heptapeptide. It was used for controlling preferential binding to poorly-differentiated colon carcinoma cells. (1)

The part includes a double terminator (BBa_B0015) consisting of BBa_B0010 and BBa_B0012. It works in the forward direction with a forward efficiency of 0.984[CC] and 0.97[JK].

BBa_K206000 is an arabinose induced e.coli promoter. We decided to work with Arabinose Induced Promoter in the middle of our construct to understand if FimH works without putting arabinose and if ButCoaT works with arabinose in the medium.

BBa_B0034 is a ribosome binding site with the efficiency of 1. It is responsible for the recruitment of the ribosomes during the initiation of protein translation.


In order to kill cancerous cells, we decided to overproduce butyrate. Butyrate is a four carbon, short chain fatty acid that inhibits cancer. It induces apoptosis and differentiation, inhibits proliferation of tumorous cells in colon flora. It is produced by the bacterial fermantation of carbohydrates in colon. (2) Butyrate is formed by many pathways which one of them begins with Acetyl-CoA. Acetyl-CoA is readily present in the cells so we wanted to find an enzyme that directly converts it to butyrate, which is ButCoaT. ButCoaT converts acetyl CoA to butyrate by the reaction Butanoyl-CoA + Acetate <=> Butanoic acid + Acetyl-CoA. And BBa_K2052018 is the sequence which codes for ButCoaT.

Modeling

       MODELING1.jpeg




Reference

1. Kelly, K. A., Jones, D. A., (2003). Isolation of a Colon Tumor Specific Binding Peptide Using Phage Display Selection

2. Hassig, C.A., Tong, J.K., Schreiber, S.L. (1997). Fiber-derived Butyrate and the Prevention of Colon Cancer